SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-030574
Filing Date
2014-08-29
Accepted
2014-08-29 17:41:57
Documents
1
Period of Report
2014-08-27

Document Format Files

Seq Description Document Type Size
1 rrd415257.html 4  
1 rrd415257.xml 4 8453
  Complete submission text file 0001181431-14-030574.txt   9825
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address
Business Address
KOLLURI KRISHNA KITTU (Reporting) CIK: 0001270521 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 141076053